Pharmacologic blood sugar control and weight loss therapies have recently seen several newly approved products. These include glucagon-like peptide 1 (GLP-1) agonists, which have received interest from clinicians, patients, and the general public alike. This drug class is now often used by those who are not facing true weight-management issues and among patients without diabetes, as they are approved and intended. How much do you know about GLP-1 agonists such as semaglutide and tirzepatide? Make sure you know key indications, contraindications, and adverse events for these increasingly popular drugs with this short quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L. Windle. Rapid Rx Quiz: GLP-1 Agonists - Medscape - May 03, 2023.